DNAJB4
Basic information
Region (hg38): 1:77979175-78017964
Links
Phenotypes
GenCC
Source:
- congenital myopathy 21 with early respiratory failure (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital myopathy 21 with early respiratory failure | AR | Cardiovascular | Among other features, the condition may include hypertrophic cardiomyopathy, and awareness may allow early diagnosis and management | Cardiovascular; Musculoskeletal; Neurologic | 36264506; 36344539 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAJB4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | 10 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 0 | 0 |
Variants in DNAJB4
This is a list of pathogenic ClinVar variants found in the DNAJB4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-77992848-C-T | DNAJB4-related disorder | Likely benign (Feb 27, 2024) | ||
1-78005114-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
1-78005164-A-C | not specified | Uncertain significance (Apr 28, 2023) | ||
1-78005184-G-A | Congenital myopathy 21 with early respiratory failure | Pathogenic (Jul 16, 2024) | ||
1-78005208-C-T | DNAJB4-related disorder | Uncertain significance (Jun 01, 2024) | ||
1-78005267-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
1-78005291-A-G | Congenital myopathy 21 with early respiratory failure | Pathogenic (Jul 16, 2024) | ||
1-78013065-G-C | not specified | Uncertain significance (Aug 12, 2022) | ||
1-78013188-G-C | not specified | Uncertain significance (Aug 08, 2023) | ||
1-78013224-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
1-78013277-G-C | not specified | Uncertain significance (Dec 01, 2022) | ||
1-78013372-G-A | not specified | Uncertain significance (Sep 03, 2024) | ||
1-78013384-C-T | not specified | Uncertain significance (Mar 31, 2024) | ||
1-78013542-A-G | not specified | Uncertain significance (Mar 30, 2024) | ||
1-78013597-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
1-78016018-T-C | Congenital myopathy 21 with early respiratory failure | Pathogenic (Jul 16, 2024) | ||
1-78016023-G-C | not specified | Uncertain significance (Feb 11, 2022) | ||
1-78016041-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
1-78016089-A-T | Congenital myopathy 21 with early respiratory failure | Pathogenic (Jul 16, 2024) | ||
1-78016095-G-A | not specified | Uncertain significance (Jun 05, 2024) | ||
1-78016108-G-T | not specified | Uncertain significance (Jan 26, 2023) | ||
1-78016134-C-G | not specified | Uncertain significance (Oct 29, 2024) | ||
1-78016156-G-GT | DNAJB4-related disorder | Uncertain significance (Jun 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNAJB4 | protein_coding | protein_coding | ENST00000370763 | 3 | 38790 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0162 | 0.962 | 125728 | 0 | 16 | 125744 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.21 | 138 | 184 | 0.750 | 0.00000925 | 2220 |
Missense in Polyphen | 23 | 47.995 | 0.47921 | 583 | ||
Synonymous | 0.273 | 59 | 61.7 | 0.956 | 0.00000308 | 641 |
Loss of Function | 2.00 | 5 | 12.7 | 0.394 | 8.43e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000737 | 0.0000462 |
European (Non-Finnish) | 0.000107 | 0.000105 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable chaperone. Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro) (PubMed:24318877). {ECO:0000269|PubMed:24318877}.;
Intolerance Scores
- loftool
- 0.438
- rvis_EVS
- -0.32
- rvis_percentile_EVS
- 31.46
Haploinsufficiency Scores
- pHI
- 0.620
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.606
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.948
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnajb4
- Phenotype
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;response to unfolded protein;response to heat;positive regulation of ATPase activity;chaperone cofactor-dependent protein refolding
- Cellular component
- nucleoplasm;cytosol;plasma membrane
- Molecular function
- ATPase activator activity;protein binding;unfolded protein binding;chaperone binding